Omnicell Inc. Aktie
?
Deine Einschätzung
Omnicell Inc. Aktie
Was spricht für und gegen Omnicell Inc. in den nächsten Jahren?
Pro
Kontra
Rendite von Omnicell Inc. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Omnicell Inc. | -1,67 % | -3,80 % | 0,57 % | 31,11 % | -8,76 % | -48,32 % | -68,39 % |
| Healthequity Inc. | 0,00 % | 1,35 % | 7,91 % | -15,25 % | -3,85 % | 45,63 % | 11,61 % |
| Bruker Corp. | 5,54 % | 29,23 % | 72,79 % | 64,34 % | 32,51 % | -19,33 % | - |
| Myriad Genetics | 0,11 % | 10,38 % | -8,16 % | -3,88 % | -30,36 % | -83,07 % | -83,57 % |
Kommentare
News
Investment Advisor Sells $6.6 Million Worth of Medical Solutions Stock, According to Recent SEC Filing
On April 29, 2026, Avory & Company, LLC disclosed in a U.S. Securities and Exchange Commission (SEC) filing that it sold 156,571 shares of Omnicell (NASDAQ:OMCL), an estimated $6.55 million
Why Omnicell Stock Trounced the Market on Tuesday
Omnicell (NASDAQ: OMCL) is off to a roaring start this year, at least as far as its quarterly performance is concerned. On Tuesday, it published its first earnings report of the year, and Mr. Market
Omnicell Executive Trims Holdings in $244,000 Sale as Stock Trades Near 2025 Highs
Corey J Manley, EVP & Chief Legal/Admin Officer at Omnicell (NASDAQ:OMCL), executed an open-market sale of 6,106 shares for $243,629.40 on Dec. 3, 2025, as reported in the SEC Form 4 filing.



